Catalogue

COVID-19: Updates on library services and operations.

Facilitating collaborations to develop combination investigational cancer therapies : workshop summary /
Margie Patlak, Sharyl J. Nass, and Erin Balogh , rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
imprint
Washington, D.C. : National Academies Press, c2012.
description
xiii, 103 p. : ill. ; 23 cm.
ISBN
0309220645, 9780309220644
format(s)
Book
Holdings
More Details
imprint
Washington, D.C. : National Academies Press, c2012.
isbn
0309220645
9780309220644
contents note
Introduction -- Why Combinations and Collaborations Are Necessary -- Scientific Challenges in Developing Investigational Combination Therapies -- Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations -- Financial Challenges -- Regulatory Issues -- Codevelopment of Therapies for HIV as a Model -- Examples of Collaborations Relevant to Cancer -- Wrapping Up -- Appendix A: Examples of Collaborations -- Appendix B: Workshop Agenda -- References -- Acronyms.
general note
Workshop entitled "Facilitating collaborations to develop combination investigational cancer therapies" was held June 13-14, 2011, National Academy of Sciences, Washington, D.C.
catalogue key
8778927
 
Includes bibliographical references (p. 97-99).
A Look Inside
Reviews
This item was reviewed in:
Reference & Research Book News, December 2012
To find out how to look for other reviews, please see our guides to finding book reviews in the Sciences or Social Sciences and Humanities.
Summaries
Description for Bookstore
Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.

This information is provided by a service that aggregates data from review sources and other sources that are often consulted by libraries, and readers. The University does not edit this information and merely includes it as a convenience for users. It does not warrant that reviews are accurate. As with any review users should approach reviews critically and where deemed necessary should consult multiple review sources. Any concerns or questions about particular reviews should be directed to the reviewer and/or publisher.

  link to old catalogue

Report a problem